DEPLOY

Buying guide

Versius vs ROSA in 2026

Comparing 2 humanoid robots across availability, pricing, capabilities, and verified deployments. Current as of 2026.

Key differences

On DEPLOY's record, Versius has more verified real-world deployments (4 versus 2) than ROSA as of 2026; DEPLOY counts a deployment only when confirmed at a named site with a primary source.

  • Versius has the lower recorded price.
  • Versius has more verified real-world deployments (4 vs 2).
Attribute
Introducing Versius, CMR Surgical
VersiusView full model page →
No image on file
ROSAView full model page →
ManufacturerCMR SurgicalZimmer Biomet
Form factorsurgicalsurgical
Maturitycommercialcommercial
Autonomy◐ not independently verified◐ not independently verified
Availabilityinternal-onlyenterpriseinternal-onlyenterprise
Price$750,000-$1,000,000 (analyst estimate)$1,000,000-$1,500,000 (analyst estimate)
Capability claims
  • Assists surgery (teleoperated-assisted, claimed)
  • Assists surgery (teleoperated-assisted, claimed)
Brain——
Verified deployments42Zimmer Biomet, Zimmer Biomet
Privacy practices——
Sources on file2414

Track this matchup

Get told the moment Versius or ROSA changes. Verified changes only, the second they are real. No press-release noise.

Versius

Verified changes only. No press-release noise.

ROSA

Verified changes only. No press-release noise.

Editorial summaries

Versius

CMR Surgical's Versius (and Versius Plus) is a modular, multi-arm, soft-tissue minimal-access surgical robot from UK-based CMR Surgical, and the international-soft-tissue archetype of DEPLOY's surgical cluster. Its modular multi-arm architecture is a deliberate contrast to the monolithic design of Intuitive's da Vinci: it is teleoperated and software-driven, capturing telematic, video, and outcome data.

On regulatory status (a correction worth recording): Versius is US-FDA-cleared for cholecystectomy via a De Novo authorization in October 2024, with Versius Plus cleared via 510(k) on December 18, 2025 (also cholecystectomy) and a gynecology 510(k) submitted April 29, 2026 (pending); it is not broadly 'US-pending', only the gynecology indication is. It is CE-marked and commercial across Europe, Latin America, AMEA, and Australia. As enterprise B2B surgical equipment sold to hospitals, there is no consumer price.

ROSA

Zimmer Biomet's ROSA (Robotic Surgical Assistant) is a single articulated robotic arm coupled to optical navigation and 2D/3D planning software, and the mid-size, cross-domain archetype of the orthopedic sub-cohort: it spans orthopedics and neurosurgery. The arm positions and guides instruments but moves only on surgeon command; it does not cut or place autonomously (AI-augmented, surgeon-controlled).

Current Zimmer Biomet variants are ROSA Knee (total knee arthroplasty, imageless X-Atlas workflow, cleared January 25, 2019; 'ROSA Knee with OptimiZe' cleared November 14, 2025), ROSA Hip (direct-anterior total hip arthroplasty specifically, cleared August 18, 2021), ROSA ONE Brain (cranial neurosurgery: biopsy, SEEG, DBS, and endoscopy, cleared February 11, 2019), and ROSA Shoulder (cleared February 2024). Made by Zimmer Biomet (NYSE: ZBH).

Two cap-flags: ROSA Spine is not a current Zimmer Biomet variant (it left in the 2022 ZimVie spinoff), and Zimmer Biomet's autonomy ambitions run through its separate Monogram acquisition, not ROSA. As enterprise B2B surgical equipment, there is no consumer price.

Common questions

How do Versius and ROSA differ?
On DEPLOY's record, Versius has more verified real-world deployments (4 versus 2) than ROSA as of 2026; DEPLOY counts a deployment only when confirmed at a named site with a primary source. Versius has the lower recorded price. Versius has more verified real-world deployments (4 vs 2).
What is the difference between Versius and ROSA?
Versius and ROSA are both surgical robots on the DEPLOY registry. They differ in maker, maturity, price, verified deployments, and how much of their autonomy is independently verified. See the table above for the full head-to-head; each figure is sourced.
Which is cheaper, Versius or ROSA?
Versius has the lower recorded price on the DEPLOY registry than ROSA. Prices are sourced; see each record for whether the figure is a manufacturer target, an estimate, or an actual sale price.
Is Versius or ROSA more autonomous?
On the DEPLOY registry, neither Versius nor ROSA has capabilities independently verified as fully autonomous yet; their recorded capabilities are teleoperated-assisted, demonstrated, or vendor-claimed. See the table for each capability's verification status.
Which has more verified deployments, Versius or ROSA?
Versius has more verified deployments (4) on the DEPLOY registry than ROSA (2). DEPLOY counts a deployment only when confirmed at a named site with a primary source.

Recent coverage

Related comparisons

Keep researching

Keep reading

All surgical robotsRegistry Every verified record in the category.VersiusModel The full model page.ROSAModel The full model page.CMR SurgicalRecord The maker's verified record.Zimmer BiometRecord The maker's verified record.Versius vs da Vinci (and Ion)Compare Another head-to-head.

Ask the registry

For AI assistants

Use DEPLOY in Claude, Cursor, and other AI assistants

Connect any MCP-aware assistant to the live registry. Ask about robot deployments, incidents, and regulations and get answers grounded in verified data instead of training memory.

Install instructionsDownload for Claude Desktop

Machine-readable: this page as markdown.

← Back to all consumer robots